The Role of Antioxidant Supplementation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review
Open Access
- 1 January 2025
- journal article
- review article
- Published by Wiley in European Journal of Cancer Care
- Vol. 2025 (1)
Abstract
Background: Patients undergoing hematopoietic stem cell transplantation (HSCT) often face complications during the acute posttransplantation period. HSCT complications are linked to oxidative stress (OS) mechanisms due to accumulation of reactive oxygen species. Researchers hypothesize that antioxidant levels may modify OS immediately after HSCT. Objective: This systematic review aimed to collect evidence on the role of antioxidant supplementation in determining the outcomes and complications of HSCT. Study Design: A systematic search of two databases was conducted, including studies published until January 2024. Inclusion criteria involved clinical original studies focusing on adults and children undergoing HSCT who received antioxidant supplementation during and/or after HSCT. Results: The review included 20 eligible studies, featuring antioxidants such as N‐acetyl cysteine, vitamin C, zinc, selenium, vitamin E, and melatonin. Outcomes examined included immune system recovery, engraftment, oral mucositis, liver toxicity, nephrotoxicity, and acute graft‐versus‐host disease. The findings indicate an unclear association between antioxidant use and complications after HSCT. The certainty of evidence for these outcomes was low or very low. Conclusions: Although the use of antioxidants in HSCT patients has been deemed safe and has even been associated with positive outcomes in some studies, the necessity for antioxidant supplementation during HSCT remains uncertain. Further large randomized controlled trials are necessary to ascertain antioxidant requirements and establish precise supplementation protocols for HSCT patients.Keywords
This publication has 71 references indexed in Scilit:
- Conditioning therapy with N‐acetyl‐L‐cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantationAmerican Journal of Hematology, 2023
- Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled studyMedical Oncology, 2019
- Influence of Zinc Deficiency and Severe Mucositis in Patients Undergoing Hematopoietic Stem Cell TransplatationTransplantation and Cellular Therapy, 2018
- N‐acetyl‐L‐cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantationAmerican Journal of Hematology, 2018
- A double-blind, randomized, controlled trial onN-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantationHematological Oncology, 2014
- Serial Profile of Vitamins and Trace Elements during the Acute Phase of Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2014
- The effect of zinc sulfate in the prevention of high‐dose chemotherapy‐induced mucositis: a double‐blind, randomized, placebo‐controlled studyHematological Oncology, 2011
- 397: Use of N-acetylcysteine for hepatic veno-occlusive disease prophylaxis in pediatric hematopoietic stem cell transplant patientsTransplantation and Cellular Therapy, 2007
- Tolerance and safety of vitamin E: A toxicological position reportFree Radical Biology and Medicine, 1992
- Vitamin E in the treatment of chemotherapy-induced mucositisThe American Journal of Medicine, 1992